Ribavirin Inhibits West Nile Virus Replication and Cytopathic Effect in Neural Cells
The Journal of Infectious Diseases2000Vol. 182(4), pp. 1214–1217
Citations Over TimeTop 1% of 2000 papers
Abstract
West Nile virus (WNV) is an emerging mosquito-borne pathogen that was reported for the first time in the Western hemisphere in August 1999, when an encephalitis outbreak in New York City resulted in 62 clinical cases and 7 deaths. WNV, for which no antiviral therapy has been described, was recently recovered from a pool of mosquitoes collected in New York City. In anticipation of the recurrence of WNV during the summer of 2000, an analysis was made of the efficacy of the nucleoside analogue ribavirin, a broad-spectrum antiviral compound with activity against several RNA viruses, for treatment of WNV infection. High doses of ribavirin were found to inhibit WNV replication and cytopathogenicity in human neural cells in vitro.
Related Papers
- → The combination of type I interferon and ribavirin has an inhibitory effect on mouse hepatitis virus infection(2007)3 cited
- Therapeutic Effect of Ribavirin on Bronchiolitis by Three Kinds of Medication(2009)
- [In vitro inhibition of respiratory syncytial virus with combined ribavirin and an oral preparation of traditional Chinese medicine Hu Fei].(2003)
- In vitro antiviral activity of Ribavirin on parainfluenza viruses(III )(2005)
- → The combination of type I interferon and ribavirin has an inhibitory effect on mouse hepatitis virus infection(2006)